Abstract
We studied the effects of the synthetic peptide Livagen on activity of ribosomal genes, denaturation parameters of heterochromatin, polymorphism of structural C-heterochromatin, and variability of facultative heterochromatin in lymphocytes from old people. Livagen induced activation of ribosomal genes, decondensation of pericentromeric structural heterochromatin, and release of genes repressed due to age-related condensation of euchromatic regions in chromosomes. Our results indicate that Livagen causes de-heterochromatinization (activation) of chromatin, which is realized via modification of heterochromatin and heterochromatinized regions in chromosomes from old people.
MeSH terms
-
Aged
-
Aged, 80 and over
-
Cells, Cultured
-
Chromatin / drug effects
-
Chromatin / metabolism*
-
Chromosomes, Human / drug effects
-
Chromosomes, Human / metabolism
-
Chromosomes, Human, Pair 1 / drug effects
-
Chromosomes, Human, Pair 1 / metabolism
-
Chromosomes, Human, Pair 16 / drug effects
-
Chromosomes, Human, Pair 16 / metabolism
-
Chromosomes, Human, Pair 9 / drug effects
-
Chromosomes, Human, Pair 9 / metabolism
-
Heterochromatin / drug effects
-
Heterochromatin / metabolism
-
Humans
-
Lymphocytes / cytology
-
Lymphocytes / drug effects
-
Lymphocytes / metabolism*
-
Nucleolus Organizer Region / drug effects
-
Nucleolus Organizer Region / metabolism
-
Oligonucleotides / pharmacology*
-
Oligopeptides
-
Peptides / pharmacology*
-
Silver / metabolism
-
Sister Chromatid Exchange / drug effects
-
Staining and Labeling
Substances
-
Chromatin
-
Heterochromatin
-
Livagen
-
Oligonucleotides
-
Oligopeptides
-
Peptides
-
Silver